About the CardioScout™ by CorNav
The CardioScout™ Epicardial Access Platform
CardioScout is a single use minimally invasive device platform for the fully articulated delivery of catheters under direct vision into the epicardium to the therapy target or targets on the surface of the beating heart. This results in a safer, faster, and more precise treatment with better clinical outcomes and lower hospital costs.
James Fonger MD – Founder and CEO
-
Minimally invasive cardiothoracic surgeon
-
30 years of academic and private practice
-
185 Publications and presentations
-
8 Cardiac related patents
-
Founded and exited two device companies
The CorNav Management Team
Chris Mulvanny - CFO
-
17 years in life sciences
-
7 years medtech finance
-
Former Investment Banker
-
Clinical and Operating roles with Zimmer, St. Jude Medical, CVRx
Larry Blankenship – CTO
-
Oversees and directs the company design and manufacturing operations
-
35 years medical device products
-
12 US Patents - 12 publications
-
Di of Engineering for divisions of Eli Lilly, Pfizer & Battelle Labs and 4 Startups.
Protective hood
- Creates pericardial space
- Protects critical structures
- Keeps camera lens clear
Video Camera
- Full color high resolution
LED Illumination
- Self contained - no fiber to
outside the body
Small overall catheter diameter
- Inserted subxyphoid
- Enhanced agility and navigation
Ultrasound imaging capability
- Myocardial wall characterization
- Coronary artery detection
- Confirmation of therapy delivery
Scope working channel
- For ablation or injection catheters
Visualize, Navigate, and Precisely Deliver
Ablation or Injection Therapies
IP Portfolio
Foundational US Patent issued Jan. 25, 2022
Mayo Clinic Collaborations
Contact: info@cornav.co